영업 문의 +82-2-6105-4350
지원 센터

지역

Korea

North America

Europe

EN | DE | ES | FR | IT

China 中国

Japan 日本

APAC

Latin America

PORTUGUESE | SPANISH

산업 분야

생명 과학

소비재

화학

미용

Veeva_Logo
제품
Clinical
Regulatory
Safety
Quality
Medical
Commercial
Data
Veeva AI
Research Sites
Industries
Demo Center

VEEVA Development Cloud

Veeva Clinical Platform

Clinical Operations

Veeva eTMF

실사 준비 상태 유지

Veeva CTMS

연구 시작부터 끝까지 포괄적으로 관리

Veeva Payments

임상 시험 기관에 더 빠르게 비용 지급

Veeva Study Startup

임상연구 사이트를 신속하게 활성화

Veeva RTSM

무작위 배정 및 임상약 공급 관리

Veeva Site Connect

임상 정보 공유를 자동화

Veeva Study Training

관련 교육의 간소화 및 자동화

Veeva Disclosures

임상 시험 디스클로저의 일원화

Veeva OpenData Clinical

임상시험 관리자와 기관 데이터 제공

Clinical Data

Veeva EDC

사이트 데이터의 수집 및 확인

Veeva CDB

연구 데이터 집계 및 정리

Veeva eConsent

임상시험 참여자 경험 개선

Veeva eCOA

연구 설계부터 마무리까지 완전한 데이터 플로우

신생 제약바이오 기업을 위한 Veeva Basics 살펴보기
임상연구 기관을 위한 솔루션 자세히 알아보기
Veeva Vault Platform에 대해 알아보기
Patient Solution에 대해 알아보기

VEEVA Development Cloud

Veeva RIM

Veeva Registrations

글로벌 등록 관리

Veeva Submissions

제출물 계획 및 관리

Veeva Submissions Publishing

보건 당국에 게시

Veeva Submissions Archive

제출물 내역에 접속 관리

Veeva Vault Platform에 대해 알아보기

VEEVA Development Cloud

Veeva Safety

Veeva Safety

관리 감독으로 위험 경감

Veeva SafetyDocs

약물감시 컨텐츠 관리

Veeva Vault Platform 자세히 알아보기

VEEVA QUALITY CLOUD

Content

Veeva QualityDocs

GxP 문서를 제어

Veeva Station Manager

제조 스테이션별 적합한 컨텐츠 제공

Training

Veeva Training

역할 기반 적격성 및 컴플라이언스 보장

Veeva LearnGxP

공인 e러닝 과정에 접속

Process

Veeva QMS

모든 품질 프로세스를 한 곳에서 관리

Veeva Batch Release

확신을 갖고 더욱 빠르게 출시 결정

Veeva Validation Management

종이 없는 밸리데이션 관리 및 실행

Veeva Product Surveillance

의료기기의 시판 후 안전 관리 단순화

Lab

Veeva LIMS

실시간 출하 승인을 위해 QC 시험실 최적화

신생 제약바이오 기업을 위한 Veeva Basics 살펴보기
CDMO 및 Generics 조직을 위한 솔루션 자세히 알아보기
Veeva Vault Platform에 대해 알아보기

Veeva Medical Suite

Engagement

다양한 채널 간 학술적 교류 증진

Content

학술 컨텐츠의 중앙 집중화 및 확장

Inquiry Management

학술 질의 접수 및 처리 자동화

Deep Data

적합한 전문가 식별, 인게이지먼트 계획 및 학술 인지도 측정

Veeva Vault Platform 자세히 알아보기

VEEVA COMMERCIAL SOLUTIONS

Software

CRM Suite

다양한 채널을 넘나드는 원활한 인게이지먼트

Events Management

대면, 버추얼, 및 하이브리드 이벤트

Field Planning

테리토리 설계 및 얼라인먼트

Master Data Management

정확한 그리고 표준화된 고객 MDM

데이터 사이언스 및 분석 플랫폼

보다 빠른 인사이트를 위한 통합 커머셜 데이터

Content & DAM

규모에 맞추어 확장 가능한 규정 준수 컨텐츠

Medical Communications

컨텐츠 및 문의 관리

Marketing Analytics

캠페인 측정, 타겟팅 및 인사이트

Data

Reference Data

완전한 HCP 및 HCO 프로필

Deep Data

KOL 프로필 및 주요 어카운트 데이터

트랜잭션 데이터

미국 시장을 위한 환자 및 처방 데이터

Pulse Data

HCP 액세스 및 인게이지먼트 데이터

Services

Business Consulting

전략 자문 서비스

Analytics

세그멘테이션 및 타겟팅을 위한 인사이트

Digital Events

이벤트 계획 서비스


By Need

Digital Engagement
Modular Content
Segmentation & Targeting
 
DTC Advertising
Launch Excellence

VEEVA DATA CLOUD

Reference Data

Veeva OpenData Commercial

완전한 HCP 및 HCO 프로필

Veeva OpenData Clinical

정확한 사이트와 임상시험 연구자 데이터

Deep Data

Veeva Link Key People

KOL들에 대한 심층 데이터

Veeva Link Key Accounts

주요 어카운트에 대한 심층 데이터

Veeva Link Medical Insights

메디컬 인사이트의 가속화

Veeva Link Workflow

사용자 정의 워크플로우 애플리케이션

Transaction Data

Veeva Compass Patient

익명의 환자 데이터 (longitudianl data)

Veeva Compass Prescriber

HCP, HCP, HCO, ZIP 예상 데이터

Veeva Compass National

주 및 국가별 예상 데이터

Pulse Data

Veeva CRM Pulse

HCP 액세스를 위한 인게이지먼트 데이터

Services

Business Consulting

전략 자문 서비스

Analytics

세그멘테이션 및 타겟팅을 위한 인사이트

FOR VAULT PLATFORM
& VEEVA APPLICATIONS

Veeva AI

AI Agents

보다 빠른 속도로 더욱 효과적인 AI 도입

AI Shortcuts

엔드 유저의 역량 강화를 위한 AI 기반 자동화

RESEARCH SITE SOLUTIONS

Veeva SiteVault

Study Connect

연구 의뢰사와 협업할 수 있는 단 하나의 플랫폼

eRegulatory

업무 부담없이 규정 준수 상태 유지

Industries

Life Sciences

Pharma and Biotech

R&D, 메디컬 그리고 커머셜 솔루션

Consumer Health

임상연구로부터 상용화까지의 솔루션

Animal Health

동물 건강을 위한 맞춤형 애플리케이션

MedTech

컨텐츠 및 데이터 관리의 효율화

Consumer Products

Consumer Packaged Goods

안전성, 신뢰, 그리고 지속 가능성을 위한 제품을 보다 신속하게 출시

Food & Beverage

식품안전, 품질, 클레임 및 규정 준수 외

Speciality Chemicals

엔터프라이즈 규모 확장을 고려한 혁신 가속화 및 운영 우수성

Demo Center

Development Cloud

Vault Quality

Medical Suite

Commercial Cloud

서비스

Services

Consulting Services
Education Services
Support & Community

Partners

Services Partners
Content Partners
CRO Partners
Product Partners
Data Partners
고객
리소스
이벤트

All Events

R&D and Quality Summit
Europe Japan Korea North America
Commercial Summit
Asia Pacific China Europe India Japan Korea Latin America North America

Featured Events

R&D and Quality Summit, U.S

Boston • September 9-10, 2024

Korea Summit,
R&D and Quality | Commercial

Seoul • Oct 15, 2024

Commercial Summit,
Europe

Madrid • November 19-21, 2024

Commercial Summit, U.S.

Watch On Demand

R&D and Quality Summit,
Europe

Stay Informed

Veeva 정보

About Veeva

Leadership
Public Benefit Corporation
Corporate Citizenship
Investors 
Partners
Trust

Contact Us

Careers

Veeva Careers 
Generation Veeva

News

Announcements
Press Coverage
Veeva Blog
  • Home
  • Contact
  • 제품
    • Clinical Solutions
      • VEEVA Development Cloud
      • Veeva Clinical Platform
      • Clinical Operations
      • Veeva eTMF
      • Veeva CTMS
      • Veeva Payments
      • Veeva Study Startup
      • Veeva RTSM
      • Veeva Site Connect
      • Veeva Study Training
      • Veeva Disclosures
      • Veeva OpenData Clinical
      • Clinical Data
      • Veeva EDC
      • Veeva CDB
      • Veeva eConsent
      • Veeva eCOA
      • 신생 제약바이오 기업을 위한 Veeva Basics
      • 임상연구 기관을 위한 솔루션
      • Veeva Vault Platform
      • Patient Solution
    • Regulatory Solutions
      • VEEVA Development Cloud
      • Veeva RIM
      • Veeva Registrations
      • Veeva Submissions
      • Veeva Submissions Publishing
      • Veeva Submissions Archive
      • Veeva Vault Platform
    • Safety Solutions
      • VEEVA Development Cloud
      • Veeva Safety
      • Veeva SafetyDocs
      • Veeva Vault Platform
    • Quality Solutions
      • VAULT QUALITY
      • Content
      • Veeva QualityDocs
      • Vault Station Manager
      • Training
      • Veeva Training
      • Veeva LearnGxP
      • Process
      • Veeva QMS
      • Veeva Batch Release
      • Veeva Validation Management
      • Veeva Product Surveillance
      • Lab
      • Veeva LIMS
      • 신생 제약바이오 기업을 위한 Veeva Basics
      • CDMO 및 Generics 조직을 위한 솔루션
      • Veeva Vault Platform
    • Medical Solutions
      • Veeva Medical Suite
      • Engagement
      • Content
      • Inquiry Management
      • Deep Data
      • Veeva Vault Platform
    • Commercial Solutions
      • VEEVA COMMERCIAL SOLUTIONS
      • Software
      • CRM Suite
      • Events Management
      • Field Planning
      • Master Data Management
      • 데이터 사이언스 및 분석 플랫폼
      • Content & DAM
      • Medical Communications
      • Marketing Analytics
      • Data
      • Reference Data
      • Deep Data
      • 트랜잭션 데이터
      • Pulse Data
      • Services
      • Business Consulting
      • Analytics
      • Digital Events
    • Data Solutions
      • VEEVA DATA CLOUD
      • Reference Data
      • Veeva OpenData Commercial
      • Veeva OpenData Clinical
      • Deep Data
      • Veeva Link Key People
      • Veeva Link Key Accounts
      • Veeva Link Medical Insights
      • Veeva Link Workflow
      • Transaction Data
      • Veeva Compass Patient
      • Veeva Compass Prescriber
      • Veeva Compass National
      • Pulse Data
      • Veeva CRM Pulse
      • Services
      • Business Consulting
      • Analytics
    • Veeva AI
      • VEEVA AI
      • Veeva AI
      • AI Agents
      • AI Shortcuts
    • Research Site Solutions
      • RESEARCH SITE SOLUTIONS
      • Veeva SiteVault
      • Study Connect
      • eRegulatory
    • Industries
      • INDUSTRIES
      • Veeva SiteVault
      • Pharma and Biotech
      • Consumer Health
      • Animal Health
      • MedTech
      • Consumer Products
      • Consumer Packaged Goods
      • Food & Beverage
      • Speciality Chemicals
  • 서비스
    • Services Overview
    • Consulting Services
    • Education Services
    • Support & Community
    • Veeva Partners
  • 고객
  • 리소스
  • 이벤트
    • All Events
    • Commercial Summit
      • Asia Pacific
      • China
      • Europe
      • India
      • Japan
      • Korea
      • Latin America
      • North America
    • R&D Summit
      • Europe
      • Japan
      • Korea
      • North America
  • Veeva 정보
    • Leadership
    • Public Benefit Corporation
    • Corporate Citizenship
    • Investors
    • Partners
    • Industry Collaborations
    • Trust
    • Careers
    • Generation Veeva
    • News
    • Veeva Blog
    • Contact Us
    •  
Home · Resources · Industry Reports

Industry Reports

  • Download PDF

VEEVA PULSE FIELD TRENDS REPORT Q1 2024

HCP에 대한 엑세스가 감소하고 있는 상황에서도, 옴니채널로 통합된 고객 인게이지먼트를 활용하는 것은 이점이 됩니다.

18개월 전, 바이오제약 기업은 60%의 HCP과 인게이먼트가 가능하였지만, 현재는 45% 수준에 불과합니다. 2022년에 업계가 경험했던 높은 접근 수준은 팬데믹 이후에 벌어진 이상 현상이었고, 이후 이러한 추세에서 다시 정상 수준으로 돌아오고 있는 것으로 파악됩니다. HCP도 이러한 경향과 마찬가지로 3개 이하의 바이오제약 기업과만 선택적으로 인게이지먼트를 진행하는 경향을 보이고 있습니다.

그럼에도 불구하고, 바이오제약 기업들은 HCP와 그들의 이같이 제한된 시간을 최대한 활용할 수 있는 새로운 방법을 찾고 있습니다. 또한 인게이지먼트가 가능한 HCP의 범위나 방문횟수와 같은 전통적인 성과 측정방식을 넘어선 각각의 HCP에게 필요한 것을 시기적절하게 제공하기 위해 어떻게 우선순위화 할 것인지에 대한 새로운 모델들이 지속적으로 개발되고 있는 것을 확인할 수 있습니다.
HCP가 필요로 하는 시점에 필요한 컨텐츠를 제공할 수 있도록 개인화, 실시간 커뮤니케이션 채널, 연관성 있는 컨텐츠들의 중요성이 점점 증가하고 있습니다. 그리고 세일즈, 마케팅, 메디컬이 통합적으로 연결되어 고객에게 일관된 인게이지먼트를 제공하는 것은 필드 팀과 HCP 사이에 수준 높은 신뢰 관계를 구축할 수 있도록 합니다.

Veeva HCP 자문위원회의 자문위원인 비뇨기과 전문의 Dr. Vital Hevia는 다음과 같이 이야기합니다.

“환자에게 가장 맞는 치료의 효과를 얻기위해 , 신뢰할 수 있는 고품질의 제품 정보, HCP를 위한 학술 교육, 연구 결과를 통한 인사이트 등 3가지를 바이오제약 업계가 제공해 주기를 기대합니다. 의사들에게는 새로운 정보들이 지속적으로 제공되어 교육되어야 하며, 바이오제약 인더스트리와의 모든 상호작용은 다음 커뮤니케이션의 내용에 반영되어야 합니다.”

Veeva Business Consulting 팀이 제공하는 심층 분석을 통해 세일즈, 마케팅, 메디컬 전반에 걸쳐 보다 연결된 접근 방식으로 HCP 관계를 확장하고, 환자에게 필요한 의약품을 제공할 수 있는 방법을 알아보시기 바랍니다.

Thank you,

Dan Rizzo
Global Head of Veeva Business Consulting


HCP access declined from 60% to 45%

HCP access in the U.S. is back to pre-pandemic levels, dropping from 60% in 2022 to 45% in 2024.
A number of underlying factors continue to influence decreasing HCP access — including
increased market consolidation, health system restrictions, growing patient loads, and the
diversity and complexity of modern medicine.

U.S. HCP Access, 2010–2024

Access also varies greatly by specialty and channel, as seen in the figure below. The hardest-to-reach specialties are oncology, internal medicine, and psychiatry. HCPs who are accessible via both in-person and video represent an increasing share of overall access compared to prior years.

U.S. HCP Access by Top Specialty and Channel

Half of accessible HCPs meet with three or fewer companies

HCPs remain highly selective when it comes to engagement with biopharmas — half of accessible HCPs meet with three or fewer companies. HCP access also varies greatly by specialty. Internal medicine, oncology, psychiatry, and urology remain the most restrictive specialties, with nearly 30% of HCPs restricting access to just one company.

U.S. HCP Selectivity by Top Specialty

Connected engagement models strengthen HCP relationships

Although access has declined back to pre-pandemic levels, the way biopharmas engage HCPs has evolved significantly during this time. Connected engagement models — where sales, marketing, and medical work together seamlessly — are extending conversations with customers, responding more quickly to HCPs’ needs, and improving treatment adoption.

Now, there are early signs the industry is engaging HCPs in a more connected way. Here’s how a connected engagement model improves outcomes and delivers a better customer experience.

Connected HCP Engagement

Reach out to Veeva Business Consulting to find out how you can use Veeva Pulse data to create a coordinated approach across sales, marketing, and medical.


Global and Regional Trends

This report highlights global and regional field engagement trends from Veeva Pulse data gathered between January 2023 and March 2024. Veeva Pulse data is sourced from Veeva’s aggregated CRM activity, including field engagement stats from all instances of Veeva CRM globally. In this report, all comparisons are year-over-year, Q1 2023 to Q1 2024, unless otherwise noted.

Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Global trends

Figure 1: Channel mix evolution, global

Figure 2: Channel mix, global


Global field team activity
Weekly activity per user by engagement channel

Figure 3: Activity by region, global

Figure 4: Activity by user type, global

Figure 5: Activity by company size, global


Global engagement quality Consolidation of key quality metrics

Figure 6: Approved email volume, global

Figure 7: Content usage by channel, global

Figure 8: Veeva CRM Engage meeting duration, global

Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

U.S. market trends

Figure 9: Channel mix evolution, U.S.

Figure 10: Channel mix, U.S.


U.S. field team activity Weekly activity per user by engagement channel

Figure 11: Activity, U.S.

Figure 12: Activity by user type, U.S.

Figure 13: Activity by company size, U.S.


U.S. engagement quality Consolidation of key quality metrics

Figure 14: Approved email volume, U.S.

Figure 15: Content usage by channel, U.S.

Figure 16: Veeva CRM Engage meeting duration, U.S.

Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Europe market trends

Figure 17: Channel mix evolution, Europe

Figure 18: Channel mix, Europe


Europe field team activity Weekly activity per user by engagement channel

Figure 19: Activity by country, EU5

Figure 20: Activity by user type, Europe

Figure 21: Activity by company size, Europe


Europe engagement quality Consolidation of key quality metrics

Figure 22: Approved email volume, Europe

Figure 23: Content usage by channel, Europe

Figure 24: Veeva CRM Engage meeting duration, Europe

Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Asia market trends

Figure 25: Channel mix evolution, Asia

Figure 26: Channel mix, Asia


Asia field team activity Weekly activity per user by engagement channel

Figure 27: Activity by country, Asia

Figure 28: Activity by user type, Asia

Figure 29: Activity by company size, Asia


Asia engagement quality Consolidation of key quality metrics

Figure 30: Approved email volume, Asia

Figure 31: Content usage by channel, Asia

Figure 32: Veeva CRM Engage meeting duration, Asia

Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Latin America market trends

Figure 33: Channel mix evolution, Latin America

Figure 34: Channel mix, Latin America


Latin America field team activity Weekly activity per user by engagement channel

Figure 35: Activity by country, Latin America

Figure 36: Activity by user type, Latin America

Figure 37: Activity by company size, Latin America


Latin America engagement quality Consolidation of key quality metrics

Figure 38: Approved email volume, Latin America

Figure 39: Content usage by channel, Latin America

Figure 40: Veeva CRM Engage meeting duration, Latin America


Appendix: Data dictionary

Metric definitions

  • Channel mix evolution over time: Weekly Veeva CRM activity volume broken down by the channel of engagement (in-person, phone, video, email, chat, or text)
  • Channel mix: Total Veeva CRM activity volume broken down by engagement channel percentage
  • Weekly activities per user: The average weekly number of Veeva CRM activities submitted per number of users active in Veeva CRM
  • Approved email volume: Volume of approved emails sent via Veeva CRM
  • Email open rate: Percentage of approved emails opened at least once out of all approved emails sent via Veeva CRM
  • Email click rate: Percentage of approved emails clicked at least once out of all approved emails sent via Veeva CRM
  • In-person % CLM usage: Percentage of in-person engagements that leveraged content in Veeva CRM
  • Video % CLM usage: Percentage of video engagements that leveraged content in Veeva CRM
  • Veeva CRM Engage meeting % CLM usage: Percentage of Veeva CRM Engage meetings that leveraged content in Veeva CRM
  • Veeva CRM Engage meeting duration: The average duration of Veeva CRM Engage meetings in minutes

Engagement channel definitions

  • In-person: Submitted calls with a CRM Standard Metrics call channel value of ‘in-person’
  • Phone: Submitted calls with a CRM Standard Metrics call channel value of ‘phone’
  • Video: Veeva CRM Engage calls and video calls via other platforms that are then recorded as calls in Veeva CRM with a Standard Metrics call channel value of ‘video’
  • Email: Approved emails and emails sent via other platforms that are then recorded as calls in Veeva CRM with a Standard Metrics call channel value of ‘email’
  • Chat or text: Submitted calls with a CRM Standard Metrics call channel value of ‘chat or text’

User type definitions

  • Sales: Users that have been classified with the ‘sales’ value in the CRM Standard Metrics user type field
  • Key account manager: Users that have been classified with the ‘key account manager’ value in the CRM Standard Metrics user type field
  • Medical: Users that have been classified with the ‘medical’ value in the CRM Standard Metrics user type field
  • Top global biopharma: Top 17 global biopharma companies by revenue
  • Rest of industry: All other biopharmas

Region definitions

  • Global: All markets globally
  • Europe: Albania, Andorra, Armenia, Aruba, Austria, Azerbaijan, Belarus, Belgium, Bermuda, Bosnia and Herzegovina,
    Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, French Polynesia, Georgia, Germany,
    Greece, Greenland, Guadeloupe, Guernsey, Hungary, Ireland, Italy, Jersey, Latvia, Lithuania, Luxembourg, Macedonia,
    Malta, Martinique, Republic of Moldova, Monaco, Montenegro, Netherlands, New Caledonia, Norway, Poland, Portugal,
    Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
  • Asia: Australia, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, Cocos (Keeling) Islands, Indonesia, Japan,
    Kazakhstan, Republic of Korea, Kyrgyzstan, Malaysia, Mongolia, Myanmar, Nauru, Nepal, New Zealand, Philippines,
    Samoa, Singapore, Solomon Islands, Sri Lanka, Taiwan, Tajikistan, Thailand, Turkmenistan, Uzbekistan, Vietnam
  • Latin America: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa
    Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico,
    Nicaragua, Panama, Paraguay, Peru, Trinidad and Tobago, Uruguay, Venezuela

Methodology

The Veeva Pulse Field Trends Report is a quarterly industry benchmark for global and regional healthcare professional
(HCP) engagement across the life sciences industry. The report is based on proprietary Veeva Pulse data and insights
from field engagement activities of more than 80% of all industry representatives worldwide (Asia Pacific, Europe, Latin
America, and the United States). Veeva CRM Standard Metrics — now used industrywide — provide the basis for
consistent collection and measurement of engagement KPIs, including channel mix and productivity across regions,
roles, and market segments. The findings are based on:

  • Approximately 600 million annual global field activities captured in Veeva CRM and Veeva CRM Engage
  • 80 billion prescription (Rx) and medical (Mx) records captured in Veeva Compass Patient, U.S.-specific
    anonymous patient longitudinal data that includes prescriptions, procedures, and diagnoses
  • 3+ million profiles containing publications, clinical trials, conferences, associations, guidelines, grants,
    payments, social media, news mentions, and influence on community practice from Veeva Link Key People across 85+ countries and 24 therapeutic areas
  • Global reference data of healthcare professionals, healthcare organizations, and affiliations from OpenData Commercial, containing addresses, emails, specialties, demographics, and compliance data (license
    information and industry identifiers) available in 100+ countries today and 115+ countries by the end of 2024

The Veeva Pulse Field Trends Report delivers insights that inform the industry and help field teams align their strategy to key
market trends for improved commercial success. The global Veeva Business Consulting team also helps customers inform
their strategies using industry benchmarking with Veeva Pulse data.

*All trending chart insights (except Figure 7) are calculated using an average weekly percent change during the specified time period.




footer-logo
Clinical 솔루션
Regulatory 솔루션
Quality 솔루션
Safety 솔루션
Medical 솔루션
Commercial 솔루션
산업 분야
서비스
고객
리소스
이벤트
커리어
사이트맵
연락처
연락처
+82-2-6105-4350
kr_info@veeva.com
한국 지사
Veeva Systems Korea
서울시 강남구 테헤란로 87길, 36
도심공항타워 19층
소셜 미디어 팔로우
Veeva Systems - 글로벌 생명 과학 산업을 위한 클라우드 기반 소프트웨어 | © Copyright 2025 Veeva Systems
Cookie Preferences | 개인 정보 보호 정책 | 약관